CRS: BJMC
Position: Pharmacist of Record
CRS: Whitman-Walker
CRS: JHU
Position: Pharmacist, PharmD, Investigational Drug Pharmacy
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
